In this report, we show that HHV-6 establishes a productive in vivo infection of thyroid cells from HT patients, that infected thyrocytes become a target for innate NK killing, and that HT patients have increased CD4+ and CD8+ T-cell responses to HHV-6 U94 protein. This evidence concerns the gene CD8A and hematocrit.